Doing Less Can Be Doing More for Healthcare – the Biggest Takeaway From ASCO 2018
Health Populi
JUNE 5, 2018
” Ultimately, as much as 70% of the patients in this early-sage, hormone-receptor HER-2 negative tumor population could avoid chemotherapy. Its findings will greatly expand the number of patients who can forgo chemotherapy without compromising their outcomes. We are de-escalating toxic therapy.”
Let's personalize your content